Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
If KY19382 succeeds in Phase II and III clinical trials, it would provide the first validated pharmaceutical targeting the CXXC5-Wnt axis for hair loss
Skarpanska-Stejnborn A, Pilaczynska-Szczesniak L, Basta P, Deskur-Smielecka E, Woitas-Slubowska D, Adach Z
Key characteristics include: Sterile, laboratory-grade solution Contains a bacteriostatic preservative Suitable for peptide reconstitution and dilution Clear, colorless solution Designed for professional laboratory research Quality Features Sterile and laboratory tested Manufactured under strict quality standards Securely sealed for product integrity Carefully packaged for safe transport Designed for professional research environments Reliable and consistent formulation Handling and Storage Store in a cool, dry environment Keep vial tightly sealed until use Protect from heat and direct sunlight Handle using proper sterile laboratory techniques Follow established laboratory protocols during preparation and use Proper storage and handling help maintain sterility, stability, and research consistency
Notably, some muscle groups, especially the rectus abdominis, psoas major, and paraspinal muscles, reportedly showed more evident changes
Schuetze SM, Wathen JK, Lucas DR, Choy E, Samuels BL, Staddon AP, et al
US$ 26.38
US$ 25.05
US$ 21.10
US$ 20.08
